US Patent Issued to UCB BIOPHARMA on Sept. 29 for "Tau-binding antibodies" (British, Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,288, issued on Sept. 29, was assigned to UCB BIOPHARMA SRL (Brussels).

"Tau-binding antibodies" was invented by Kerry Louise Tyson (Slough, Great Britain), Terence Seward Baker (Slough, Great Britain), Georges Mairet-Coello (Brussels), Patrick Downey (Brussels), Jean-Philippe Courade (Brussels) and David Edward Ormonde Knight (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Tau-binding antibodies and binding fragments thereof."

The patent was filed on June 30, 2023, under Application No. 18/344,930.

*For further information, including images, charts and tables, please visit: http://patft.uspto...